SCHEMBL996487

SCHEMBL996487

Cc1cc(COc2ccc(S(=O)(=O)NCC(C(=O)NO)N3CCCC3)cc2)c2ccccc2n1

nearest known ligand 0.98

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 16/20 0.98
MMP3 P08254 11/20 0.98
MMP1 P03956 11/20 0.98
ADAM33 Q9BZ11 5/20 0.98
ADAM9 Q13443 2/20 0.85
ADAM10 O14672 2/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL996486 1.00 ADAM17 (0.98) ADAM17MMP3MMP1ADAM33ADAM9
SCHEMBL997375 0.99 ADAM17 (1.00) ADAM17MMP3MMP1ADAM33ADAM9
SCHEMBL996786 0.99 ADAM17 (1.00) ADAM17MMP3MMP1ADAM33ADAM9
SCHEMBL997402 0.99 ADAM17 (1.00) ADAM17MMP3MMP1ADAM33ADAM9
SCHEMBL996785 0.99 ADAM17 (1.00) ADAM17MMP3MMP1ADAM33ADAM9
SCHEMBL996311 0.99 ADAM17 (1.00) ADAM17MMP3MMP1ADAM33ADAM9
Hydrochloric Acid SCHEMBL2680365 0.98 ADAM17 (0.98) ADAM17MMP3MMP1ADAM33ADAM9
Hydrochloric Acid SCHEMBL2680362 0.98 ADAM17 (0.98) ADAM17MMP3MMP1ADAM33ADAM9
SCHEMBL2681981 0.98 ADAM17 (0.95) ADAM17MMP3MMP1ADAM33ADAM9
SCHEMBL2681978 0.98 ADAM17 (0.95) ADAM17MMP3MMP1ADAM33ADAM9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448931-B1 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine GALDERMA RES & DEV (FR) 2015-05-27 EP claimed
US-8772478-B2 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics GALDERMA RESEARCH & DEVELOPMENT (FR) 2014-07-08 US claimed
US-20120116072-A1 NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS GALDERMA RESEARCH & DEVELOPEMENT (FR) 2012-05-10 US claimed
EP-2448931-A1 NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS Galderma Research & Development (FR) 2012-05-09 EP claimed
WO-2011001088-A1 NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-01-06 WO claimed
EP-2448931-B1 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine GALDERMA RES & DEV (FR) 2015-05-27 EP disclosed
US-8772478-B2 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics GALDERMA RESEARCH & DEVELOPMENT (FR) 2014-07-08 US disclosed
US-20120116072-A1 NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS GALDERMA RESEARCH & DEVELOPEMENT (FR) 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120116072-A1 NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS TYR, ARSA, STS ADAM17 3458/4885MMP3 3872/4885MMP1 2795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.